Related Experiment Video
Updated: Apr 27, 2026
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
From genes to drugs: target validation in Caenorhabditis elegans
Ann E Sluder1, Ralf Baumeister2
1Cambria Biosciences LLC, 8A Henshaw St., Woburn, MA 01801, USA.
Abstract:
A central challenge in post-genomic drug discovery is selection of relevant therapeutic targets from a large pool of candidates, so that resources are invested productively. Key to meeting this challenge is demonstrating target function in disease-related pathways in vivo. The nematode Caenorhabditis elegans, a well-characterized experimental system for genetic analysis of biological regulatory pathways, provides a powerful means of assessing the impact of modulating target function on biological processes, thus facilitating selection of high-value targets.:
Insights
Selecting effective drug targets is crucial for productive research. The nematode Caenorhabditis elegans offers a powerful model for assessing target function in disease pathways, aiding in the selection of high-value therapeutic targets.
Area of Science:
- Genomics
- Drug Discovery
- Molecular Biology
Background:
- Post-genomic drug discovery faces challenges in selecting effective therapeutic targets from numerous candidates.
- Efficiently identifying and validating drug targets is essential for productive investment in research and development.
Purpose of the Study:
- To highlight the utility of Caenorhabditis elegans as a model organism for assessing therapeutic target function.
- To demonstrate how validating target function in vivo can facilitate the selection of high-value drug targets.
Main Methods:
- Utilizing Caenorhabditis elegans, a well-characterized model system, for genetic analysis of biological pathways.
- Assessing the impact of modulating specific gene targets on biological processes within the organism.
Main Results:
- Demonstrated the effectiveness of C. elegans in evaluating target function within disease-related pathways.
- Showcased the model's capability to assess the functional impact of target modulation in vivo.
Conclusions:
- Caenorhabditis elegans provides a powerful platform for validating drug targets in a biological context.
- This approach facilitates the selection of high-value therapeutic targets, optimizing resource allocation in drug discovery.
More Related Videos
10:08Surveying Low-Cost Methods to Measure Lifespan and Healthspan in Caenorhabditis elegans
Published on: May 18, 2022
11:20Osmotic Avoidance in Caenorhabditis elegans: Synaptic Function of Two Genes, Orthologues of Human NRXN1 and NLGN1, as Candidates for Autism
Published on: December 11, 2009